Cited 0 times in 
Cited 0 times in 
Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 최진섭 | - |
| dc.contributor.author | 민진식 | - |
| dc.date.accessioned | 2025-08-14T05:00:57Z | - |
| dc.date.available | 2025-08-14T05:00:57Z | - |
| dc.date.issued | 1997-02 | - |
| dc.identifier.issn | 0513-5796 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/207010 | - |
| dc.description.abstract | The postoperative levels of carcinoembryonic antigen (CEA) and the actual half life (T1/2) of CEA were evaluated to ascertain their potency in predicting the recurrence of colorectal cancer after curative surgery in patients who had an abnormally high level of preoperative carcinoembryonic antigen (CEA, > or = 5 ng/ml). Ninety-four patients who underwent curative surgery were enrolled and 24 patients (25.5%) had recurrence during the follow-up period (median: 30 months, range: 2-69 months). T1/2 of CEA for all patients ranged from 1.2 days to 88.1 days, with a median of 4.4 days. T1/2 of CEA (mean +/- standard deviation) was 11.7 +/- 17.9 days in recurrent patients, whereas it was 6.2 +/- 4.9 days in patients without recurrence (p = 0.0224). The patients' age, gender, size of the tumor, location of the tumor, pre-, and postoperative CEA level, pathologic type of the tumor and Dukes stage had no significance in recurrence. The 1-year, 2-year, and 5-year disease-free survival rates were 95.1%, 81.1%, and 73.8% in patients with postoperative CEA levels less than 5 ng/ml (n = 62), respectively, and 71.4%, 64.8%, and 64.8% in patients with postoperative CEA levels higher than or equal to 5 ng/ml (n = 32), respectively (p = 0.04). Patients were divided into Group S (T1/2 of CEA < 4.4 days, n = 43) and Group L (T1/2 of CEA > or = 4.4 days, n = 51). The 1-year, 2-year, and 5-year disease-free survival rates were 95.3%, 85.1%, and 77.7% in Group S, respectively, and 80%, 67.5%, and 64.1% in Group L, respectively (p = 0.0261). In conclusion, the disease-free survival of colorectal cancer patients was prolonged in patients who had a short T1/2 of CEA or a low level of postoperative CEA. In high-risk colorectal cancer patients with an abnormally high level of preoperative CEA, recurrence may be predicted by checking an early postoperative CEA level and/or by a simple calculation of the actual half life of CEA. | - |
| dc.description.statementOfResponsibility | open | - |
| dc.language | English | - |
| dc.publisher | Yonsei University | - |
| dc.relation.isPartOf | YONSEI MEDICAL JOURNAL | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.subject.MESH | Adolescent | - |
| dc.subject.MESH | Adult | - |
| dc.subject.MESH | Aged | - |
| dc.subject.MESH | Aged, 80 and over | - |
| dc.subject.MESH | Carcinoembryonic Antigen / blood* | - |
| dc.subject.MESH | Colorectal Neoplasms / blood* | - |
| dc.subject.MESH | Colorectal Neoplasms / surgery* | - |
| dc.subject.MESH | Female | - |
| dc.subject.MESH | Half-Life | - |
| dc.subject.MESH | Humans | - |
| dc.subject.MESH | Male | - |
| dc.subject.MESH | Middle Aged | - |
| dc.subject.MESH | Neoplasm Recurrence, Local | - |
| dc.subject.MESH | Postoperative Period | - |
| dc.subject.MESH | Predictive Value of Tests | - |
| dc.subject.MESH | Retrospective Studies | - |
| dc.title | Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Surgery (외과학교실) | - |
| dc.contributor.googleauthor | Jin Sub Choi | - |
| dc.contributor.googleauthor | Jin Sik Min | - |
| dc.identifier.doi | 10.3349/ymj.1997.38.1.1 | - |
| dc.contributor.localId | A04199 | - |
| dc.contributor.localId | A01411 | - |
| dc.relation.journalcode | J02813 | - |
| dc.identifier.eissn | 1976-2437 | - |
| dc.identifier.pmid | 9100477 | - |
| dc.contributor.alternativeName | Choi, Jin Sub | - |
| dc.contributor.affiliatedAuthor | 최진섭 | - |
| dc.contributor.affiliatedAuthor | 민진식 | - |
| dc.citation.volume | 38 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 7 | - |
| dc.identifier.bibliographicCitation | YONSEI MEDICAL JOURNAL, Vol.38(1) : 1-7, 1997-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.